Literature DB >> 9217047

Noncytotoxic drug therapy in children with unresectable desmoid tumors.

H Lackner1, C Urban, R Kerbl, W Schwinger, A Beham.   

Abstract

BACKGROUND: Antiestrogens and nonsteroidal antiinflammatory drugs have been shown to be effective in adult patients with unresectable or recurrent desmoid tumors. It appears that the growth of these tumors is influenced by estrogen, and that antiestrogen treatment may inhibit further proliferation of tumor cells. Nonsteroidal antiinflammatory drugs are thought to be effective through their interference with prostaglandin metabolism.
METHODS: Two children with unresectable desmoid tumors (aggressive fibromatosis) were treated with tamoxifen (1 mg/kg orally, twice daily) and diclofenac (2 mg/kg rectally, twice daily).
RESULTS: At last follow-up, tumor regression and growth arrest were maintained for more than 51 months in 1 child with rapidly growing recurrent fibromatosis of the thoracic wall. Another child with an inoperable desmoid tumor of the submandibular region had stable disease since the initiation of treatment.
CONCLUSIONS: This is the first report describing this treatment approach in childhood fibromatosis. Combined therapy with endocrine therapy and nonsteroidal antiinflammatory drugs may be a nonaggressive alternative to chemotherapy and radiotherapy in the treatment of children with inoperable desmoid tumors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9217047     DOI: 10.1002/(sici)1097-0142(19970715)80:2<334::aid-cncr22>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  20 in total

1.  Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients.

Authors:  Daniel Robert Quast; Ralph Schneider; Emanuel Burdzik; Steffen Hoppe; Gabriela Möslein
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

2.  [Aggressive fibromatosis in the jaw and facial region with bone involvement. A review].

Authors:  L Seper; P Hoppe; B Kruse-Lösler; A Büchter; U Joos; J Kleinheinz
Journal:  Mund Kiefer Gesichtschir       Date:  2005-11

3.  Low-dose chemotherapy with methotrexate and vinblastine for patients with desmoid tumors: relationship to CTNNB1 mutation status.

Authors:  Yoshihiro Nishida; Satoshi Tsukushi; Hiroshi Urakawa; Shunsuke Hamada; Eiji Kozawa; Kunihiro Ikuta; Yuichi Ando; Naoki Ishiguro
Journal:  Int J Clin Oncol       Date:  2015-04-22       Impact factor: 3.402

4.  Multimodal treatment of desmoid tumours: the significance of local control.

Authors:  Bella Pajares; Esperanza Torres; Begoña Jiménez; Isabel Sevilla; Ana Rodríguez; José Manuel Rico; José Manuel Trigo; Emilio Alba
Journal:  Clin Transl Oncol       Date:  2011-03       Impact factor: 3.405

Review 5.  Aggressive fibromatosis of the head and neck: a new classification based on a literature review over 40 years (1968-2008).

Authors:  Astrid L Kruse; Heinz T Luebbers; Klaus W Grätz; Joachim A Obwegeser
Journal:  Oral Maxillofac Surg       Date:  2010-12

Review 6.  The Role of Pharmacotherapeutic Agents in Children with Desmoid Tumors.

Authors:  David P Douglass; Fariba Navid; Aaron R Weiss
Journal:  Paediatr Drugs       Date:  2022-07-29       Impact factor: 3.930

7.  Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: results of a Children's Oncology Group (COG) phase II study.

Authors:  Stephen X Skapek; James R Anderson; D Ashley Hill; David Henry; Sheri L Spunt; William Meyer; Simon Kao; Fredric A Hoffer; Holcombe E Grier; Douglas S Hawkins; R Beverly Raney
Journal:  Pediatr Blood Cancer       Date:  2012-12-31       Impact factor: 3.167

8.  Aggressive fibromatosis (desmoid tumour) of the head and neck: a benign neoplasm with high recurrence.

Authors:  Raghunath Prabhu; Arjun Natarajan; Rajgopal Shenoy; Kuldeep Vaidya
Journal:  BMJ Case Rep       Date:  2013-06-28

9.  Clinicopathological study of three cases of infantile fibromatosis of the orbit.

Authors:  Kengo Hayashi; Nobutada Katori; Yoshiro Otsuki; Kyoko Ohno-Matsui
Journal:  Int Ophthalmol       Date:  2014-02-15       Impact factor: 2.031

10.  Desmoid fibromatosis in pediatric patients: management based on a retrospective analysis of 59 patients and a review of the literature.

Authors:  Caroline Oudot; Daniel Orbach; Véronique Minard-Colin; Jean Michon; Pierre Mary; Christophe Glorion; Sylvie Helfre; Jean-Louis Habrand; Odile Oberlin
Journal:  Sarcoma       Date:  2012-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.